The DOI matches its Crossref record.
Neurons May Live for Decades with Neurofibrillary Tangles
Abstract
Neurons containing neurofibrillary tangles (NFT) are one of the pathological hallmarks of Alzheimer disease (AD). It is known that this population of neurons express gene products and thus function to some degree, but it is unknown how long these neurons may survive with NFT. It is also thought that the formation of NFT results in the death of neurons. Using quantitative data on neuron loss and NFT formation as a function of disease duration, we have generated a computer program that models both the degeneration of CA1 hippocampal neurons and the formation of NFT in these neurons in AD. Modeling various neuron survival times with NFT and altering selected assumptions upon which the models are based, we arrive at the conclusions that 1) CA1 hippocampal neurons survive with NFT for about 20 years, and 2) NFT may not be obligatory for death of CA1 hippocampal neurons in AD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“NFT‐containing neurons can survive for decades, 7 , 8 indicating that NFTs are neither obligatory nor sufficient to induce neuronal dysfunction and toxicity.”
From Senescence, brain inflammation, and oligomeric tau drive cognitive decline in Alzheimer's disease: Evidence from clinical and preclinical studies (2024) · cites this paper as [8]
Citations
Cites
Still being checked.
Cited by
Sorted by citations
Items 301–370 of 370
Li, S., & Bhalla, R. (2024) · Neurochemical Research · doi:10.1007/s11064-024-04178-w · Cited by 8
Tau Fibrillation Induced by Heparin or a Lysophospholipid Show Different Initial Oligomer Formation
Rasmussen, H. Ø., Nielsen, J., de Poli, A., Otzen, D. E., & Pedersen, J. S. (2023) · Journal of Molecular Biology · doi:10.1016/j.jmb.2023.168194 · Cited by 7
The Role of Glycogen Synthase Kinase-3 (GSK-3) in Alzheimer’s Disease
Medina, M., & Avil, J. (2011) · InTech eBooks · doi:10.5772/16879 · Cited by 7
Vickers, J. C., Tan, A., & Dickson, T. C. (2003) · Brain Research · doi:10.1016/s0006-8993(03)02429-6 · Cited by 7
Oyanagi, K., Yamazaki, M., Hashimoto, T., Asakawa, M., Wakabayashi, K., & Takahashi, H. (2015) · Neuropathology · doi:10.1111/neup.12185 · Cited by 7
Neuropathologie und biologische Marker degenerativer Demenzen
Jellinger, K. A., & Rösler, N. (2000) · Der Internist · doi:10.1007/s001080050557 · Cited by 7
Ka, J. (2001) · Journal für Kardiologie (Krause & Pachernegg GmbH) · Cited by 7
Li, W., Han, Y., Wang, P., & Qiao, S. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70803 · Cited by 6
Apoptosis vs Nonapoptotic Mechanisms in Neurodegeneration
Jellinger, K. A. (2003) · Humana Press eBooks · doi:10.1007/978-1-59259-297-5_2 · Cited by 6
Oxidative Stress and Neurodegeneration: An Inevitable Consequence of Aging? Implications for Therapy
Rodrigues, R., Bonda, D., Perry, G. L., Castellani, R. J., Casadesús, G., Lee, H., Lee, H. P., Wang, X., Zhu, X., Petersen, R. B., et al. (2010) · Springer eBooks · doi:10.1007/978-90-481-8553-5_10 · Cited by 6
La apoptosis en las enfermedades neurodegenerativas: evidencias y controversias
Jiménez-Del-Río, M., & Velez‐Pardo, C. (2001) · Revista de Neurología · doi:10.33588/rn.3209.2000495 · Cited by 6
Mitochondrial Quality Control in Alzheimer’s Disease: Insights from Caenorhabditis elegans Models
Ganguly, U., Carroll, T., Nehrke, K. W., & Johnson, G. V. W. (2024) · Antioxidants · doi:10.3390/antiox13111343 · Cited by 5
Making tau amyloid models in vitro: a crucial and underestimated challenge
Broc, J., Piersson, C., & Fichou, Y. (2025) · FEBS Letters · doi:10.1002/1873-3468.70022 · Cited by 5
Hoglund, B. K., Carfagno, V. F., Olive, M. F., & Leyrer‐Jackson, J. M. (2022) · International review of neurobiology · doi:10.1016/bs.irn.2022.10.004 · Cited by 4
Oncogenic parallels in Alzheimer disease
Raina, A. K., Garrett, M. R., Previll, L. A., Obrenovich, M. E., Hartzler, A., Webber, K. M., Casadesús, G., Lee, H., Perry, G. L., Zhu, X., et al. (2006) · OhioLink ETD Center (Ohio Library and Information Network) · Cited by 4
Addressing the Complex Etiology of Alzheimer‘s Disease: the Role of P25/Cdk5
Mungenast, A. E., & Tsai, L. (2011) · Future Neurology · doi:10.2217/fnl.11.22 · Cited by 3
Neurofibrillary Tangle Formation as a Protective Response to Oxidative Stress in Alzheimer’s Disease
Nunomura, A., Takeda, A., Moreira, P. I., Castellani, R. J., Lee, H., Zhu, X., Smith, M. A., & Perry, G. L. (2009) · Springer eBooks · doi:10.1007/978-0-387-87995-6_9 · Cited by 3
Braak, H., & Tredici, K. D. (2014) · Advances in anatomy, embryology and cell biology · doi:10.1007/978-3-319-12679-1_5 · Cited by 2
Dementias Caused by Persistent Pathogens and the Protective Role of HLA Against them
James, L. M., & Georgopoulos, A. P. (2020) · Journal of Neurology and Neuromedicine · doi:10.29245/2572.942x/2019/1.1260 · Cited by 2
EFhd2 co-aggregates with monomeric and filamentous tau in vitro
Soliman, A. S., Umstead, A., Lamp, J. A., & Vega, I. E. (2024) · Frontiers in Neuroscience · doi:10.3389/fnins.2024.1373410 · Cited by 2
Current and future treatments of memory complaints and Alzheimer’s disease
Summers, W. K. (2011) · Therapy · doi:10.2217/thy.11.60 · Cited by 2
Knell, S., Thal, D. R., & Lipp, V. (2022) · Verlag Karl Alber eBooks · doi:10.5771/9783495999370 · Cited by 2
Is there room for Darwinian medicine and the hygiene hypothesis in Alzheimer pathogenesis?
Griffin, W. S. T., & Mrak, R. E. (2009) · Birkhäuser Basel eBooks · doi:10.1007/978-3-7643-8903-1_14 · Cited by 2
Robertson, J. D., Lovell, M. A., Buchholz, B. A., Xie, C., & Markesbery, W. R. (2001) · Journal of Radioanalytical and Nuclear Chemistry · doi:10.1023/a:1013299426601 · Cited by 2
Katsuse, O., Iseki, E., Suzuki, K., & Kosaka, K. (2001) · Neuropathology · doi:10.1046/j.1440-1789.2001.00411.x · Cited by 2
Correlation between tau phosphorylation sites and tangle morphology in Alzheimer's disease
Shimazaki, M., NAKANO, H., & Kobayashi, K. (2005) · Psychogeriatrics · doi:10.1111/j.1479-8301.2005.00087.x · Cited by 2
Role of Oxidative Insult and Neuronal Survival in Alzheimer’s and Parkinson’s Diseases
Nunomura, A., Moreira, P. I., Zhu, X., Cash, A., Smith, M. A., & Perry, G. L. (2007) · Springer eBooks · doi:10.1007/978-0-387-72076-0_14 · Cited by 2
Tau Oligomers as Potential Drug Target for Alzheimer Disease (AD) Treatment
Kayed, R. (2011) · InTech eBooks · doi:10.5772/16682 · Cited by 1
Ihara, Y. (2002) · Advances in behavioral biology · doi:10.1007/978-0-306-47593-1_5 · Cited by 1
Place cell physiology in a transgenic mouse model of Alzheimer's disease
Yi, M. (2009) · Cited by 1
Ikezu, T. (2016) · Springer eBooks · doi:10.1007/978-3-319-44022-4_30 · Cited by 1
Chung, E. J., Cho, H. J., Hur, D. Y., Kim, Y. S., Lee, K., & Kim, S. J. (2022) · Journal of Korean Medical Science · doi:10.3346/jkms.2022.37.e195 · Cited by 1
Serotonin receptors - a potential target for the treatment of Alzheimer’s disease
Eremin, D. V., Kondaurova, E. M., Rodnyy, A. Y., Molobekova, K. A., Kudlay, D. A., & Naumenko, V. S. (2023) · Biochemistry (Moscow) · doi:10.31857/s0320972523120059 · Cited by 1
Alzheimer Disease: Oxidative Stress and Compensatory Responses
Moreira, P. I., Nunomura, A., Zhu, X., Lee, H., Aliev, G., Smith, M. A., & Perry, G. L. (2009) · Contemporary clinical neuroscience · doi:10.1007/978-1-60327-342-8_7 · Cited by 1
Epigenetics in mental and neurodegenerative disorders
Iatrou (2018) · Research Publications (Maastricht University) · doi:10.26481/dis.20180712ai · Cited by 1
The Role of ATP and P2X Purinoceptor 7 in the Development of Cerebral Tau
Gao, A. F. (2018) · TSpace (University of Toronto) · Cited by 1
Granic, A. (2011) · Digital Commons - University of South Florida (University of South Florida)
Hochegger, K., & Ar, R. (2007) · Journal für Kardiologie (Krause & Pachernegg GmbH)
The role of mTor in the pathogenesis of tau-related pathologies in Alzheimer Disease
Tang, Z. (2014) · Figshare
Mouse and stem cell models of frontotemporal dementia
Orr, M. E. (2012) · Montana State University ScholarWorks (Montana State University)
Polvikoski, T. M. (2004) · Työväentutkimus Vuosikirja
Acción protectora de la proteína tau en la enfermedad de Alzheimer
Luna‐Muñoz, J., Zamudio, S., de la Cruz, F., Minjarez-Vega, B., & Mena, R. (2012)
Targeting Tau Aggregation for the Diagnosis and Treatment of Alzheimer's Disease
Schafer, N. D. (2013) · OhioLink ETD Center (Ohio Library and Information Network)
dos Santos, A. C. F., & dos Santos (2012)
Albrecht, M. A., & Foster, J. K. (2016) · Springer eBooks · doi:10.1007/978-1-4939-3777-6_7
Amyloid- _ and _ in Alzheimer’s Disease
Nunomura, A., Lee, H., Zhu, X., Perry, G. L., Castellani, R. J., & Smith, M. A. (2005) · Oxidative stress and disease · doi:10.1201/9781420026559.ch6
Oxidative Adaptation in Aging and Alzheimer’s Disease
Hirai, K., Takeda, A., Nunomura, A., Smith, M. A., Lee, H., Zhu, X., Joseph, J. A., Perry, G. L., & Drew, K. L. (2005) · Oxidative stress and disease · doi:10.1201/9781420027174.ch11
Approach for Alzheimer's Disease
Tian, H. (2014)
Proxy-PET Building Blocks as a Design Element for Library Synthesis
Mallin, L. J. (2015) · Journal of Bioresource Management
Tangled tau: Active pathology or footprint of disease?
Higham, J. P. (2017) · Alzheimer s & Dementia Translational Research & Clinical Interventions · doi:10.1016/j.trci.2017.10.007
Identifying stage-specific markers of Alzheimer's disease using quantitative proteomics
Yagensky, O. (2018) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-7052
THE ROLE OF MICROTUBULE-ASSOCIATED PROTEIN TAU IN NEURONAL EXCITABILITY AND EPILEPTOGENESIS
Cloyd, R. (2021) · UKnowledge (University of Kentucky) · doi:10.13023/etd.2021.271
Ashford, J. W. (2018) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.734280398.793553881
I. Demenz: Medizinische Aspekte
Knell, S., Thal, D. R., & Lipp, V. (2022) · Verlag Karl Alber eBooks · doi:10.5771/9783495999370-17
Sasmita, A. O. (2024) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-10403
Ikezu, T. (2024) · Springer eBooks · doi:10.1007/978-3-031-68237-7_22
Microglial glutathione and glutamate: regulation mechanisms
Fry, V. A. H. (2009) · UCL Discovery (University College London)
Ye, J., Yue, R.-Z., Li, C., Wu, L., Guo, X., Zhao, Y., Wan, H., Wang, J.-Z., Gu, B., & Xiao, S. (2025) · Research Square · doi:10.21203/rs.3.rs-7655539/v1
Oxidative Stress Associated Signal Transduction Cascades in Alzheimer Disease
Petersen, R. B., Nunomura, A., Lee, H., Casadesús, G., Perry, G. L., Smith, M. A., & Zhu, X. (2009) · Contemporary clinical neuroscience · doi:10.1007/978-1-60327-342-8_8
Tau nucléaire : un acteur clé dans le stress neuronal
Sultan, A. (2010) · theses.fr (ABES) · doi:10.70675/98c582c8z1d31z4edazbbfaz92750b338b46
Auboyer, L. (2018) · theses.fr (ABES) · doi:10.70675/07243ef7zb974z4ad8z97d9zd046801798b1
Vautheny, A. (2019) · theses.fr (ABES) · doi:10.70675/1812d71aze8d9z48d6z87d1z5a23a4e81953
Étude biophysique de l'interaction protéine tau - zinc
Rocca, R. L. (2020) · theses.fr (ABES) · doi:10.70675/c975b708z273cz4f8ez9703zc6efc7ce3b5c
Nguyen, M. N., Ryu, T. H., Lee, J.-S., Hong, S.-H., Yoon, S.-E., Kim, Y.-J., & Yu, K. (2026) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2026.120169
Humanized tauopathy chimeras uncover microglial and lncRNA strategies for neuroprotectionPreprint
Qu, W., Li, F., Jang, M. W., Ye, P., Cordes, E., Aikedan, A., Hu, W., Nagiri, R. K., Wong, M. Y., Luo, W., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.07.02.736124
Investigating the role of EFhd2 protein in modulating tau pathology in a tauopathy mouse model
Soliman, A. S., Umstead, A., & Vega, I. E. (2026) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2026.1833887
Boulger, S. L., Lambie, N., Wos, J., Papageorgopoulou, M., Pastor, S. M., Adair, E., Thomas, M., Caramello, A., Fancy, N. N., Jackson, J., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.10.27.762234
Metadata
- Authors
- Morsch, R., Simon, W., & Coleman, P. D.
- Affiliations
- University of Rochester Medicine (US)
- Venue
- Journal of Neuropathology and Experimental Neurology
- Publisher
- Oxford University Press (OUP)
- Published
- 1999-02
- Volume
- 58
- Issue
- 2
- Pages
- 188-197
- ISSN
- 0022-3069 (ISSN-L)
- OpenAlex
- W2018983416
- Cited by
- 370
- References
- 0
- Citations by year
- 2026: 3 · 2025: 4 · 2024: 12 · 2023: 16 · 2022: 11 · 2021: 9 · 2020: 19 · 2019: 10 · 2018: 15 · 2017: 13 · 2016: 12 · 2015: 18 · 2014: 19 · 2013: 13 · 2012: 15
- FWCI
- 7.55
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Neuropathology & Experimental Neurology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r35ag009016-07, 5r01ag014441-05)
- National Institute on Aging (AG 08665, AG09016, R01 AG14441, P30AG008665)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- neurofibrillary tangles, Alzheimer's disease, neuronal survival, CA1 hippocampal neurons, neurodegeneration, neuronal loss, disease duration, computational modeling, neuronal cell death
- MeSH terms
- Aged, Aged, 80 and over, Alzheimer Disease, Cell Count, Cell Survival, Hippocampus, Humans, Middle Aged, Neurons, Neurofibrillary Tangles, Cellular Senescence, Disease Progression
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review